Bayer predicts that three of its drugs could reach over $1 billion in sales starting this year, helping rebuild its pipeline as its two top-selling drugs start to lose patent protection this year. The pharma giant is focusing on specialties such as cardiovascular, oncology, women's health, and cell and gene therapies . . .

Get GEN Edge Today!